Johnson & Johnson (JNJ): South Dakota Investment Council reduced its stake -8,897 shares
South Dakota Investment Council reduced its stake in Johnson & Johnson, per its Q1 2026 13F.
- 76K
- Shares reported · -8,897 vs prior quarter
- 0.35%
- Disclosed portfolio weight
- $18.5M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 18, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 16, 2025Federal contractDepartment of Veterans Affairs awarded Johnson & Johnson: $0 obligated to date
- Feb 19, 2026Federal contract · $155K obligatedDepartment of Defense awarded Johnson & Johnson: $155K obligated to date
- Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
- Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
- Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
- Mar 10, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Mar 16, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
- Mar 19, 2026Congress · 2 peopleMembers of Congress: 3 sales
- Mar 20, 2026Federal contract · $20K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $20K obligated to date
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Mar 27, 2026CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Mar 30, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
What came next
- May 28, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
- Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Jun 9, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Jun 11, 2026FDAFDA device clearance: MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System
- Jun 11, 2026Insider · First sale since 2023Officer sold ~$2.41M of JNJ shares in the open market
- Jun 25, 2026FDAFDA device clearance: Coated VICRYL (Polyglactin 910) Plus Antibacterial Suture
- Jun 25, 2026FDAFDA device clearance: ATTUNE Total Knee System; ATTUNE Cementless Knee System
- Jun 25, 2026FDAFDA device clearance: VELYS Robotic-Assisted Solution
- Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
- Jul 23, 2026FDARecall: Velys Enabling Tech Robotic-Assist Station REF: 451611001
- Jul 23, 2026Federal contract · $182K obligatedDepartment of Defense awarded Johnson & Johnson: $182K obligated to date
- Jul 25, 2026FDAFDA device clearance: MONARCH Platform (MON-000008)
- Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
- Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
- Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
- Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
- Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
How this filing works
Explore the data
Common questions
What does this filing report about Johnson & Johnson (JNJ) stock?
South Dakota Investment Council reduced its stake in Johnson & Johnson, per its Q1 2026 13F. Now 76K shares, $18.5M reported value, 0.35% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 18, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Johnson & Johnson recently?
For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the JNJ page.
Does this mean JNJ stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Johnson & Johnson
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 13, 2026
- USAspending.gov award recordNov 13, 2026
- SEC Form 144Nov 12, 2026
- House Clerk periodic transaction reportOct 30, 2026
- House Clerk periodic transaction reportOct 5, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
